Personalized Prediction of Chronic Kidney Disease Progression in Patients with Chronic Kidney Disease Stages 3-5: A Multicenter Study Using the Machine Learning Approach.

Journal: Studies in health technology and informatics
Published Date:

Abstract

Chronic Kidney Disease (CKD) is a prevalent and progressive condition that can lead to end-stage renal disease (ESRD) if left unmanaged. Accurate prediction of CKD progression, particularly in patients with CKD stages 3-5, is essential for early intervention and personalized treatment. This study utilized machine learning (ML) models to predict declines in estimated glomerular filtration rate (eGFR) over one year. The models, including LGBM and Random Forest, were trained on a large cohort of CKD patients from the Taipei Medical University Clinical Research Database (TMUCRD). LightGBM emerged as the top-performing model with AUC values of 0.76 and 0.82 for predicting 5% and 25% declines in eGFR, respectively. SHAP (Shapley Additive Explanations) analysis identified baseline eGFR, eGFR slope, and BUN as key predictive features. The results demonstrate the utility of ML in CKD management and highlight the importance of personalized prediction models for improving patient outcomes.

Authors

  • Trung Toan Duong
    International PhD program of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
  • Minh Tri Nguyen
    Institute of Data Science, College of Management, Taipei Medical University, New Taipei City, Taiwan.
  • Chia Te Liao
    Division of Nephrology, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan.
  • Ngoc Hoang Le
    Graduate Institute of Biomedical Materials and Tissue Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei City 110, Taiwan.
  • Thanh Phuc Phan
    International PhD program of Biotech and Healthcare Management,College of Management, Taipei Medical University, Taipei, Taiwan.
  • Chih Wei Huang
    International Center for Health Information Technology, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.
  • Jason C Hsu
    International Ph.D. Program in Biotech and Healthcare Management, College of Management, Taipei Medical University, Taipei, Taiwan.
  • Alex P A Nguyen
    Graduate Institute of Data Science, College of management, Taipei Medical University, Taipei, Taiwan.